100th Episode with IASLC CEO Karen Kelly, MD

Episode
100
Soundcloud
Share

In the 100th episode of IASLC's Lung Cancer Considered, host Dr. Narjust Duma interviews new IASLC CEO, Dr. Karen Kelly.  Dr. Kelly is recognized internationally for her expertise in lung cancer research and her career has been dedicated to providing enhanced cancer care through innovative and groundbreaking clinical trials. Dr. Kelly’s lung cancer research has involved all aspects of the disease from risk reduction to screening to treatment. She has been at the forefront of drug development to treat lung cancer for decades. Dr. Kelly is the first female to hold this post in the association’s almost 50-year history.

Guest
Narjust Florez Headshot 2022
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School

Other Podcast

EMPOWER-Lung 3
Episode
134
POSEIDON Trial
Episode
133
Climate Change & Lung Cancer Part 2
Episode
132
Evolution of stage III NSCLC
Episode
131